1. ScholarBank@NUS

Lingzhi Wang

rp05443

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
Main Affiliation
 
Faculty
 
Email
csiwl@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
File Format:  Adobe PDF

Results 21-37 of 37 (Search time: 0.016 seconds).

Issue DateTitleAuthor(s)
211-Jan-2018Molecular targets and anti-cancer potential of escinCheong, Dorothy HJ ; Arfuso, Frank; Sethi, Gautam ; Wang, Lingzhi ; Hui, Kam Man ; Kumar, Alan Prem ; Thai, Tran 
222017Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditionsYu F. ; Lu Y.; Tao L. ; Jiang Y.-Y. ; Lin D.-C.; Wang L. ; Petersson F. ; Yoshiyama H.; Koeffler P.H.; Goh B.-C. ; Loh K.S. 
232018Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft modelsSyn N.L.; Lim P.L.; Kong L.R.; Wang L. ; Wong A.L.-A. ; Lim C.M. ; Loh T.K.S. ; Siemeister G.; Goh B.C. ; Hsieh W.-S. 
2428-Mar-2018Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingWang, Lingzhi ; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin ; Cheow, Esther Sok Hwee ; Kong, Li Ren ; Yu, Fenggang ; Peethala, Praveen C. ; Wong, Andrea Li-Ann ; Laljibhai, Hirpara J. ; Chinnathambi, Arunachalam; Ong, Pei Shi ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Yong, Wei Peng ; Goh, Boon Cher 
252016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
262019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
271-Jan-2021Putting the BRK on breast cancer: From molecular target to therapeuticsAng, Hui Li; Yuan, Yi ; Lai, Xianning ; Tan, Tuan Zea ; Wang, Lingzhi ; Huang, Benjamin BoJun; Pandey, Vijay; Huang, Ruby Yun-Ju; Lobie, Peter E ; Goh, Boon Cher ; Sethi, Gautam ; Yap, Celestial T ; Chan, Ching Wan ; Lee, Soo Chin ; Kumar, Alan Prem 
2831-Dec-2021Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?Ma, Z; Woon, CYN; Liu, CG; Cheng, JT; You, M; Sethi, G ; Wong, ALA ; Ho, PCL ; Zhang, D; Ong, P; Wang, L ; Goh, BC 
291-Sep-2021Resveratrol for cancer therapy: Challenges and future perspectivesRen, Boxu; Kwah, Marabeth Xin-Yi; Liu, Cuiliu; Ma, Zhaowu; Shanmugam, Muthu K. ; Ding, Lingwen ; Xiang, Xiaoqiang; Ho, Paul Chi-Lui ; Wang, Lingzhi ; Ong, Pei Shi ; Goh, Boon Cher 
302018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M
312018Sorcin a Potential Molecular Target for Cancer TherapyShabnam B.; Padmavathi G.; Banik K.; Girisa S.; Monisha J.; Sethi G. ; Fan L.; Wang L. ; Mao X.; Kunnumakkara A.B.
3229-Apr-2020Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationKong, Li Ren ; Ong, Richard Weijie; Tan, Tuan Zea ; Salleh, Nur Afiqah Binte Mohamed ; Thangavelu, Matan; Chan, Jane Vin; Koh, Lie Yong Judice; Periyasamy, Giridharan; Lau, Jieying Amelia ; Le, Thi Bich Uyen; Wang, Lingzhi ; Lee, Miyoung; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Chwee Ming ; Chng, Wee Joo ; Lane, David P ; Venkitaraman, Ashok ; Hung, Huynh The; Cheok, Chit Fang ; Goh, Boon Cher 
3320-Oct-2020Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapyLi, J.; Eu, J.Q. ; Kong, L.R. ; Wang, L. ; Lim, Y.C. ; Goh, B.C. ; Wong, A.L.A. 
342019Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumorsLee M.; Hirpara J.L. ; Eu J.-Q. ; Sethi G. ; Wang L. ; Goh B.-C. ; Wong A.L. 
3518-Jan-2021Tiny mirnas play a big role in the treatment of breast cancer metastasisTeo, Andrea York Tiang; Xiang, Xiaoqiang; Le, Minh T. N. ; Wong, Andrea Li-Ann ; Zeng, Qi ; Wang, Lingzhi ; Goh, Boon-Cher 
362018TIPE family of proteins and its implications in different chronic diseasesBordoloi D.; Banik K.; Shabnam B.; Padmavathi G.; Monisha J.; Arfuso F.; Dharmarajan A.; Mao X., Lim L.H.K. ; Wang L. ; Fan L. ; Hui K.M. ; Kumar A.P. ; Sethi G. ; Kunnumakkara A.B.
372015Validation of a rapid and sensitive LC-MS/ MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: Application to human pharmacokinetics studyWang Lingzhi ; Goh, Sokhwei; Wong, Andrea; Thuya, Win Lwin; Lau, Jie Ying Amelia ; Wan, Seowching ; Ho Chi Lui, Paul ; Goh, Booncher